Nursing care
Heparin: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Heparin is an anticoagulant that works immediately by boosting antithrombin's ability to block clotting factors, mainly thrombin and factor Xa. Nurses monitor aPTT, aiming for 1.5 to 2.5 times the control value, and treat any falling platelet count as heparin-induced thrombocytopenia until proven otherwise. Protamine sulfate reverses it.
Mechanism, simply
Heparin does not dissolve clots. It binds antithrombin III and accelerates its natural ability to neutralise thrombin and factor Xa, so the coagulation cascade stalls before new clot can form. Existing clot is left to the body's own fibrinolytic system.
Unfractionated heparin acts within minutes when given intravenously, which is why it is the anticoagulant of choice when a patient needs to be therapeutic now rather than in a few hours. It has a short half-life, roughly 60 to 90 minutes, so stopping the infusion reverses most of its effect quickly even before protamine is considered.
Indications you will see on the ward
Expect heparin drips for acute venous thromboembolism, pulmonary embolism, and unstable angina or acute MI, often as a bridge before or after a procedure. It is also standard during cardiopulmonary bypass and haemodialysis circuits to stop the circuit itself from clotting.
Subcutaneous low-dose heparin is common for DVT prophylaxis in immobile surgical or medical patients. That prophylactic dose does not require aPTT monitoring, which is a distinction worth knowing on the exam and on the floor: therapeutic IV heparin is titrated to labs, prophylactic subcutaneous heparin is not.
Assessment before administration
Check baseline aPTT, platelet count, and haemoglobin/haematocrit before starting, and review for active bleeding, recent surgery, or a history of HIT before hanging the bag. Confirm the infusion pump rate against the protocol's weight-based dosing chart, since heparin is a high-alert medication with a standard requirement for independent double-checks.
Once running, aPTT is drawn on a schedule, typically six hours after a rate change, until two consecutive results fall in the therapeutic range of 1.5 to 2.5 times the control value. Platelets are trended daily. A drop of 50% or more from baseline, or a count under 150,000, is treated as heparin-induced thrombocytopenia until proven otherwise, and the infusion is stopped while it is worked up rather than continued pending a definitive test.
Toxicity and the antidote
The toxicity to watch for is bleeding: gums, urine, stool, injection sites, or a falling haemoglobin with no obvious source. An aPTT climbing well past 2.5 times control without a dose change is a warning sign before a bleed becomes visible.
Protamine sulfate reverses heparin by binding it directly and neutralising its anticoagulant effect within minutes of IV administration. It is dosed against how much heparin remains active, not the original total dose, since heparin's short half-life means less is on board the longer the infusion has been running. Protamine itself can cause hypotension and anaphylaxis, so it is given slowly with the patient monitored.
Interactions that matter
Anything else that affects clotting compounds heparin's risk: aspirin, NSAIDs, warfarin, and other anticoagulants or antiplatelets all raise bleeding risk when combined. Herbal supplements with anticoagulant properties, such as ginkgo or fish oil, deserve the same scrutiny during medication reconciliation.
Nitroglycerin infusions can reduce heparin's anticoagulant effect at high doses, so aPTT may need closer monitoring if both are running together. IM injections should be avoided entirely while a patient is heparinised, since they risk haematoma formation at the injection site.
What the patient must be told
Tell the patient to report any unusual bruising, bleeding gums, blood in urine or stool, or prolonged bleeding from a cut, and to use a soft toothbrush and electric razor while on the drug. They should avoid activities with a high fall or injury risk for the same reason.
If they are transitioning to subcutaneous heparin or an oral anticoagulant at discharge, explain the overlap period and why it exists, and make sure they know which medication they are actually taking home, since the names and doses are easy to confuse after a hospital stay.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
What is a therapeutic aPTT range on heparin?
Most protocols target 1.5 to 2.5 times the control aPTT value, though the exact range depends on the lab's reference and the institution's protocol. Results are checked roughly six hours after any dose change until stable, then less frequently once therapeutic.
How quickly does protamine sulfate work?
Protamine begins neutralising heparin within minutes of IV administration and its effect peaks quickly. It is given slowly, because rapid administration can cause hypotension, bradycardia, or an anaphylactoid reaction.
What platelet count should raise concern about HIT?
A drop of 50% or more from baseline, or an absolute count below 150,000/microlitre, especially five to ten days after starting heparin, should be treated as suspected HIT until ruled out. The infusion is typically stopped while the diagnosis is confirmed.
Does subcutaneous prophylactic heparin need aPTT monitoring?
No. Low-dose subcutaneous heparin used for DVT prophylaxis does not require routine aPTT monitoring, unlike therapeutic IV heparin, which is titrated to lab values.
Can heparin be given IM?
No. Intramuscular injections are avoided in a patient on heparin because the anticoagulant effect increases the risk of haematoma at the injection site.
More on cardiovascular
Guides on this